Advertisement
In the future

Circulating Biomarkers May Be Indicative of Stroke Risk

0
High levels of CRP, tHcy, TNFR2, and VEGF indicate significantly higher odds for incident ischemic stroke
Late-onset asthma may increase risk for incident cardiovascular disease events

Cardiovascular Disease Risk Up in Late-Onset Asthma Patients

0
Doctors should be monitoring for high blood pressure, cholesterol closely in these patients
Early exposure to diabetes mellitus or higher insulin resistance has an adverse effect on left ventricular remodeling and function

Diabetes, Insulin Resistance Adversely Affect LV Function

0
Early diabetes group has less favorable LV mass, LV ejection fraction
The gap between heart disease and the second-leading cause of death

Cancer Replaces CVD As Leading Cause of Death in 22 States

0
Cancer is also now the leading cause of death for a number of minority groups
Two genetic variants predict the cardiovascular effect of intensive glycemic control in the Action to Control Cardiovascular Risk in Diabetes trial

Two Variants ID Cardiovascular Effect of Intensive Glycemic Tx

0
Genetic risk score based on two loci is significant modulator of cardiovascular mortality response to tx
Frailty status may be able to predict outcome in older adults undergoing cardiac surgical procedures

Review: Frailty Status May Predict Outcome After Cardiac Surgery

0
Frailty may predict mortality after major cardiac surgery, functional decline after minor surgery
For patients undergoing percutaneous coronary intervention

A-Fib Tied to Adverse Outcomes in Patients Undergoing PCI

0
Condition is linked to post-procedural bleeding, heart failure, cardiogenic shock, in-hospital mortality
Many cases of life-threatening sepsis could be recognized and treated long before they cause severe illness or death

CDC Urges Prevention, Early Recognition of Sepsis

0
Know the signs of extreme response to infection; consider it a medical emergency
Prescription drug prices are skyrocketing in the United States due in large part to government regulations

Steep Rise in U.S. Drug Prices Tied to Patent Monopolies

0
Letting Medicare and Medicaid negotiate pricing would likely help bring costs down, researchers say
A disease-guided approach to statin eligibility can improve treatment specificity

Disease-Guided Approach Ups Specificity of Statin Treatment

0
Improvement in specificity for coronary heart disease events with CAC-, cPB-guided reclassification